Lung carcinoma: Analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry

Cancer

Volumn 85, Issue 11, 1999, Pages 2359-2367

  Ito, Norimasa ^a   Nakamura, Hiroshige ^a   Tanaka, Yoshiyuki ^a   Ohgi, Shigetsugu ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Intracellular cytokine analysis; Lung carcinoma; T helper type 1 and 2 cells (Th1 and Th2), T cytotoxic type 1 and 2 cells (Tc1 and Tc2); Tumor immunity; Tumor infiltrating lymphocytes

Indexed keywords

CYTOKINE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOMA; MALE; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR RECURRENCE;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOCOMPROMISED HOST; INTERFERON TYPE II; INTERLEUKIN-4; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0033152737     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990601)85:11<2359::AID-CNCR10>3.0.CO;2-A     Document Type: Article

References (30)

1. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787-93.
2. Mosmann TR, Li L, Sad S. Functions of CDS T-cell subsets secreting different cytokine patterns. Semin Immunol 1997; 9:87-92.
3. Mosmann TR, Li L, Hengartner H, Kagi D, Fu W, Sad S. Differentiation and functions of T cell subsets. Ciba Found Symp 1997;204:148-54.
4. Ferrick DA, Schrenzel MD, Mulvania T, Hsieh B, Ferlin WG, Lepper H. Differential production of interferon-γ and interleukin-4 in response to Th1-and Th2-stimulating pathogens by γ δ T cells in vivo. Nature 1995;373:255-7.
5. Jung T, Shauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993;159:197-207.
6. Picker LJ, Singh MK, Zdraveski Z, Treer JR, Waldrop SL, Bergstresser PR, et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995;86:1408-19.
7. Cruician B, Dunne P, Freidman H, Ragsdale R, Pross S, Widen R. Detection of altered T helper 1 and T helper 2 cytokine production by peripheral blood mononuclear cells in patient with multiple sclerosis utilizing intracellular cytokine detection by flow cytometry and surface marker analysis. Clin Diagn Lab Immunol 1996;3:411-6.
8. Roura-Mir C, Catalfamo M, Sospedra M, Alcalde L, PujolBorrell R, Jaraquemada D. Single-cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's and Graves disease. Eur J Immunol 1997;27: 3290-3302.
9. Nakamura H, Ishiguro K, Mori T. Different immune function of peripheral blood, regional lymph node, and tumor infiltrating lymphocytes in lung cancer patients. Cancer 1988; 62:2489-97.
10. North ME, Ivory K, Funauchi M, Webster ADB, Lane AC, Farrant J. Intracellular cytokine production by human CD4+ and CD8+ T cells from normal and immunodeficient donors using directory conjugated anticytokine antibodies and three colour flow cytometry. Clin Exp Immunol 1996; 105:517-22.
11. Annuziato F, Manetti R, Cosmi R, Galli G, Heusser CH, Romagnani S, et al. Opposite role for interleukin-4 and interferon-γ on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells. Eur J Immunol 1997;27:2239-44.
12. Angevin E, Kremer F, Gaudin C, Hercend T, Triebel F. Analysis of T-cell immune response in renal cell carcinoma: polarization to type 1-like differentiation pattern, clonal T-cell expansion, and tumor-specific cytotoxicity. Int J Cancer 1997;72:431-40.
13. Guilloux Y, Viret C, Gervois N, Drean EL, Pandolfino MC, Diez E, et al. Defective lymphokine production by most CD8+ and CD4+ tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro. Eur J Immunol 1994;24: 1966-73.
14. Kim J, Modlin RL, Moy RL, Dubinett SM, McHugh T, Nickoloff BJ, et al. IL-10 production in cutaneous basal and squamous cell carcinomas: a mechanism for evading the local T cell immune response. J Immunol 1995;155:2240-47.
15. Wang Q, Redovan C, Raymond T, Olencki T, Klein E, Kudoh S, et al. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes. Int J Cancer 1995;61:780-5.
16. Maeurer MJ, Martin DM, Castelli C, Elder E, Leder G, Storkus WJ, et al. Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in fleshly collected tumor-infiltrating lymphocytes. Cancer Immunol Immunother 1995;41:111-21.
17. Yano T, Yasumoto K, Togami M, Ishida T, Kimura G, Sugimati K, et al. Properties of recombinant interleukin 2-cultured tumor-infiltrating lymphocytes in human lung cancer. Int J Cancer 1989;43:619-23.
18. Roussel E, Gingras MC, Grimm EA, Roth JA. High expression of adhesion molecules/activation markers with little interleukin-2, interferon-γ, and tumor necrosis factor gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma. Cancer Immunol Immunother 1995;41:1-9.
19. Palmer EM, Seventer GA. Human T helper cell differentiation is regulated by the combined action of cytokines and accessory cell dependent costimulatory signals. J Immunol 1997;158:2654-62.
20. Openshaw P, Murphy EE, Hosken NA, Maino V, Davis K, Murphy K, et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med 1995;182:1357-67.
21. Chen H, Paul WE. Cultured NK1.1+ T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. J Immunol 1997;159:2240-9.
22. Hamann D, Baars PA, Hooibrink B, Lier RAW. Heterogeneity of the human CD4+ T-cell population: two distinct CD4+ T-cell subsets characterized by coexpression of CD45RA and CD45RO isoforms. Blood 1996;88:3513-21.
23. Fowler DH, Breglio J, Nagel G, Eckhaus MA, Gress RE. Allospecific CD8+ Tel and Tc2 populations in graft-versus-leukemia effect and graft-versus host disease. J Immunol 1996;157:4811-21.
24. Goedegebuure PS, Douville CC, Doherty JM, Linehan DC, Lee KY, Ganguly EK, et al. Simultaneous production of T helper-1-like cytokines and cytolytic activity by tumor-specific T cells in ovarian and breast cancer. Cell Immunol 1997;175:150-6.
25. Huang M, Wang J, Lee P, Sharma S, Mao JT, Meissner H, et al. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res 1995;55:3847-53.
26. Wojciechowska-Lacka A, Matecta-Nowak M, Adamiak E, Lacki JK, Cerkaska-Gluszak B. Serum levels of interleukin-10 and interleukin-6 in patients with lung cancer. Neoplasma 1996;43:155-8.
27. Chen YM, Yang WK, Ting CC, Tsai WY, Yang DM, Whang-Peng J, et al. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions in lung cancer patients. Chest 1997;112: 960-6.
28. Tanaka N, Gouchi A, Ohara T, Mannami T, Konaga E, Fuchimoto S, et al. Intratumoral injection of a streptococcal preparation, OK-432, before surgery for gastric cancer: a randomized trial. Cooperative Study Group of Preoperative Intratumoral Immunotherapy for Cancer. Cancer 1994;74: 3097-103.
29. Fujimoto T, Duda RB, Szilvasi A, Chen X, Mai M, O'Donnel MA. Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state. J Immunol 1997;158:5619-26.
30. Okamoto T, Harada M, Tamada K, Yoshida H, Ito O, Kong YY, et al. Local injection of OK-432 can augment the Th1 type T cell response in tumor lymph node cells and increase their immunotherapeutical potential. Int J Cancer 1997;70: 598-605.